Digital Health Startups

Hyfe develops AI-powered cough monitoring technology that continuously and unobtrusively tracks patients' cough patterns over extended periods. Its life sciences offering targets drug development and clinical trials by providing objective, longitudinal cough data.

1 investor

HyliDx develops a home-based blood testing and remote care platform for monitoring chronic kidney disease and heart failure, delivering lab-accurate results in 5 minutes from a finger-prick sample with integrated cloud AI analysis for complications prediction. The platform targets patients with advanced CKD, dialysis patients, and high-risk cardio-renal populations across North America and Europe to reduce hospitalizations and healthcare costs.

1 investor

Hyperfine develops the Swoop portable, point-of-care MRI system for brain imaging without ionizing radiation, used in clinical and research settings for infants, children, and adults. The company partners with foundations to deploy the technology for neuroimaging in conditions such as hydrocephalus and early brain development monitoring in low- and middle-income countries.

1 investor

1 investor

Hypherdata operates an e-auction marketplace platform that connects pharmaceutical companies and AI/ML developers with healthcare data providers to procure real-world medical datasets for clinical research, drug development, and AI model training. The platform facilitates competitive bidding for datasets across multiple medical specialties and imaging modalities, including data cleaning, annotation, and privacy compliance services.

1 investor

Hypno Loops is a neuroscience-based brain-training platform that uses patent-pending audio looping technology, letting users record short personal messages and phrases turned into rhythmic "Neuro Signals" paired with soundscapes to interrupt negative patterns and build mental resilience. It offers apps for adults and children (Hypno Loops and Hypno Loops Kids) grounded in Cognitive Behavioral Therapy, narrative therapy, and neuroplasticity.

1 investor

IbisVision provides a digital platform for eye care practices that includes online vision checks and remote patient monitoring to facilitate digital patient journeys. The platform enables eye care providers to attract, engage, and support patients across connected care pathways.

1 investor

IC Solutions builds the IC Pen system for digitizing paper documents and capturing biometric, legally valid electronic signatures using digital pens, tablets, signature screens and scanners. It serves healthcare, energy, industry and manufacturing, logistics, public administration and research institutions, integrating with CRM and HIS software; the company operates in Poland.

1 investor

iCAD develops AI-powered imaging solutions for breast cancer detection and risk assessment used by radiologists and clinicians globally. The company's ProFound portfolio helps providers identify cancer earlier and improve diagnostic accuracy through validated AI algorithms.

1 investor

ICBII develops molecular technology platforms designed to deliver therapeutic molecules across the blood-brain barrier to treat neurodegenerative diseases such as Parkinson's and Alzheimer's. The company focuses on advancing drug delivery capabilities for treating major diseases affecting the central nervous system.

1 investor

ICON plc is a global Contract Research Organization providing consulting and outsourced development services to pharmaceutical, biotechnology, medical device, and government organizations to accelerate drug and device development. The company supports clients across all phases of clinical development with integrated services spanning study design, patient recruitment, digital trial solutions, and commercialization.

1 investor

ICU Vision Care develops digital therapeutics for pediatric strabismus (crossed eyes), with plans to pursue FDA approval and eventual myopia management capabilities. The company operates vision care centers and provides customized vision examinations by specialized optometrists.

1 investor

Ideal Option operates office-based outpatient clinics providing medication-assisted treatment for opioid, alcohol, and other substance addictions across the United States. It serves patients seeking addiction recovery through a network of 80+ Joint Commission-accredited clinics and an in-house laboratory, accepting Medicaid, Medicare, and self-pay.

1 investor

Identifeye provides a fundus imaging platform combining a portable camera device and cloud-based portal software for retinal screening in point-of-care settings. The system serves healthcare providers and clinics conducting diabetic retinopathy and other retinal disease screenings.

1 investor

Idience is a biopharmaceutical company focused on developing and commercializing new medicines. Established in 2019 as a wholly owned subsidiary of Korean pharmaceutical group Ildong Holdings.

1 investor

IDmelon provides passwordless authentication using proximity badges and FIDO2 passkeys for healthcare organizations, enabling fast and secure access to clinical devices and applications without traditional passwords or complex MFA solutions.

1 investor

iDose TR is a procedural pharmaceutical implant that delivers travoprost therapy to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The implant uses a proprietary membrane with nanoporous material for controlled drug delivery as an alternative to daily eye drops.

1 investor

ieso develops AI-powered mental health support that integrates into existing healthcare platforms to treat anxiety and depression alongside chronic conditions. The platform targets healthcare providers, behavioral health platforms, and health plans seeking to improve care outcomes and reduce costs.

1 investor

ifeel provides a mental health platform for insurers, digital health providers, and their brokers, using AI-powered clinical triage and therapy pathways to lower claims costs and improve care outcomes for policyholders. It offers global rollouts and locally branded solutions, with clinical dashboards, risk detection, and text/video therapy delivered by psychologists across many languages.

1 investor

A medical AI company that builds diagnosis and treatment reasoning systems, smart hospital and healthcare platforms, and AI health hardware such as hearing aids and blood pressure monitors. Its products serve hospitals, primary care providers, and patients, including AI diagnostic assistants, intelligent triage, chronic disease management, and an AI health assistant.

1 investor

iFocus Health provides a data-driven digital health platform that helps patients and caregivers make informed treatment decisions for ADHD, combining AI, bioinformatics, and clinical expertise to improve treatment outcomes.

1 investor

Clinical Medical Services provides durable medical equipment, home health care, respiratory equipment, inhalation medications, home infusion services, and orthotics and prosthetics to patients across Puerto Rico through an integrated healthcare delivery system.

1 investor

Heuron develops medical AI software that analyzes brain CT and MRI images to aid physicians in diagnosing and triaging neurological conditions, including intracranial hemorrhage, large vessel occlusion, ischemic stroke, and Parkinson's disease. Its diagnostic-aid products (ICH, ELVO, ASPECTS, IPD) are intended for use by medical professionals in hospitals and stroke networks.

1 investor

IHH Healthcare is one of the world's largest private healthcare services providers, operating an integrated network of 89 hospitals across 10 countries. The company delivers hospital, primary care, and ancillary healthcare services under trusted brands including Acibadem, Mount Elizabeth, Gleneagles, and Fortis.

1 investor